Vaccinex, Inc.

$1.03-6.36%($-0.07)
TickerSpark Score
66/100
Solid
50
Valuation
60
Profitability
80
Growth
40
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VCNX research report →

52-Week Range61% of range
Low $0.31
Current $1.03
High $1.50

Companywww.vaccinex.com

Vaccinex, Inc. , a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders.

CEO
Maurice Zauderer
IPO
2018
Employees
23
HQ
Rochester, NY, US

Price Chart

+49.28% · this period
$1.49$0.91$0.34May 20Nov 18May 20

Valuation

Market Cap
$2.76M
P/E
-0.12
P/S
4.59
P/B
-0.87
EV/EBITDA
-0.09
Div Yield
0.00%

Profitability

Gross Margin
100.00%
Op Margin
-3117.30%
Net Margin
-3100.50%
ROE
776.58%
ROIC
760.66%

Growth & Income

Revenue
$601.00K · 5.44%
Net Income
$-18,634,000 · 7.98%
EPS
$-8.88 · 79.67%
Op Income
$-18,735,000
FCF YoY
6.32%

Performance & Tape

52W High
$1.50
52W Low
$0.31
50D MA
$1.00
200D MA
$0.85
Beta
0.56
Avg Volume
2.18K

Get TickerSpark's AI analysis on VCNX

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Nov 14, 24FRIEDBERG ALBERTother30,756
Nov 14, 24FRIEDBERG ALBERTother584,646
Nov 14, 24Zauderer Mauriceother46,153
Sep 18, 24Zauderer Mauriceother35,715
Sep 18, 24Zauderer Mauriceother9,768
Sep 18, 24Zauderer Mauriceother29,557
Sep 18, 24Zauderer Mauriceother38,610
Sep 18, 24Zauderer Mauriceother170,475
Sep 18, 24Zauderer Mauriceother35,715
Sep 18, 24FRIEDBERG ALBERTother25,723

Our VCNX Coverage

We haven't published any research on VCNX yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate VCNX Report →

Similar Companies